Fair Value Measurements and Investments - Schedule of Reconciliation of Carrying Value of Investments in Equity Securities (Detail) - Neo Medical [Member] $ in Thousands, SFr in Millions			12 Months Ended
	Nov. 14, 2024 CHF (SFr)	Nov. 14, 2024 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Sale of preferred equity securities	SFr 6.6	$ 7,400
Realized loss recognized in other expense, net		$ 5,800
Preferred Stock [Member]
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of equity securities beginning balance			$ 4,951	$ 6,084
Conversion of loan into preferred equity securities			8,224
Foreign currency remeasurement recognized in other income, net				388
Unrealized loss recognized in other expense, net				(1,521)
Sale of preferred equity securities			(7,396)
Realized loss recognized in other expense, net			$ (5,779)
Fair value of equity securities Ending balance				4,951
Cumulative unrealized gain (loss) on Neo Medical preferred equity securities				$ (720)